mTOR signaling in growth control and disease.

mTOR signaling in growth control and disease.
复制标题

DOI:
10.1016/j.cell.2012.03.017
复制
发表时间:
2012-04-13
期刊:
影响因子:
64.5
通讯作者:
Sabatini DM
Sabatini DM
中科院分区:
生物学1区
文献类型:
--
作者:
Laplante M;Sabatini DM

文献摘要

参考文献

被引文献

相似文献

哺乳动物雷帕霉素靶蛋白 (mTOR) 信号通路感知并整合多种环境信号来调节生物体生长和体内平衡。该通路调节许多主要的细胞过程,并与越来越多的病理状况有关,包括癌症、肥胖、2 型糖尿病和神经变性。在此,我们回顾了对 mTOR 通路及其在健康、疾病以及衰老中的作用的理解的最新进展。我们进一步讨论治疗与 mTOR 失调相关的人类病理的药理学方法。
The mammalian target of rapamycin (mTOR) signaling pathway senses and integrates a variety of environmental cues to regulate organismal growth and homeostasis. The pathway regulates many major cellular processes and is implicated in an increasing number of pathological conditions, including cancer, obesity, type 2 diabetes, and neurodegeneration. Here, we review recent advances in our understanding of the mTOR pathway and its role in health and disease as well as aging. We further discuss pharmacological approaches to treat human pathologies linked to mTOR deregulation.
DOI: 10.1038/nature06322
发表时间: 2007-11-29
期刊: NATURE
影响因子: 64.8
作者:
Cunningham, John T.;Rodgers, Joseph T.;Puigserver, Pere
通讯作者: Puigserver, Pere
DOI: 10.1126/science.1124147
发表时间: 2006-05-12
期刊: SCIENCE
影响因子: 56.9
作者:
Cota, D;Proulx, K;Seeley, RJ
通讯作者: Seeley, RJ
IRS信号传导降低会损害β细胞周期的进程和过表达β细胞S6K的转基因小鼠的存活。
DOI: 10.2337/db09-0851
发表时间: 2010-10
期刊: Diabetes
影响因子: 7.7
作者:
Elghazi L;Balcazar N;Blandino-Rosano M;Cras-Méneur C;Fatrai S;Gould AP;Chi MM;Moley KH;Bernal-Mizrachi E
通讯作者: Bernal-Mizrachi E
DOI: 10.1016/j.cmet.2009.11.010
发表时间: 2010-01
期刊: Cell metabolism
影响因子: 29
作者:
Bjedov I;Toivonen JM;Kerr F;Slack C;Jacobson J;Foley A;Partridge L
通讯作者: Partridge L
DOI: 10.1007/s11892-010-0122-6
发表时间: 2010-08-01
影响因子: 4.2
作者:
Cusi, Kenneth
通讯作者: Cusi, Kenneth